SFTI-M2

General Information


DRACP ID  DRACP05599

Peptide Name   SFTI-M2

Sequence  GRCTKSIPPICFPA

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys11; NCB: Gly1<--->Asp14

N-terminal Modification  Conjugation with Alexa Flour 488

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C66H108N18O17S2

Absent amino acids  DEHLMNQVWY

Common amino acids  P

Mass  172187

Pl  8.83

Basic residues  2

Acidic residues  0

Hydrophobic residues  4

Net charge  2

Boman Index  -831

Hydrophobicity  25

Aliphatic Index  62.86

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  9.62

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24985034

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2462

DRACP is developed by Dr.Zheng's team.